Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status:
Withdrawn
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The investigators will be looking at the efficacy of the use of once daily use of low dose
naltrexone (4.5mg) in subjects with symptomatic inflammatory bowel disease.